Latest News about ALLO
Recent news which mentions ALLO
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
From Motley Fool
50 Biggest Movers From Yesterday
October 14, 2021
From Benzinga
What 5 Analyst Ratings Have To Say About Allogene Therapeutics
October 12, 2021
Tickers
ALLO
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
Cathie Wood Goes Dumpster Diving: 3 Sagging Stocks She Just Bought
October 12, 2021
From Motley Fool
35 Biggest Movers From Friday
October 11, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher
October 08, 2021
From Benzinga
From Motley Fool
Why Allogene Therapeutics Stock Is Getting Hammered Today
October 08, 2021
Tickers
ALLO
From Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
From Benzinga
From Benzinga
28 Stocks Moving In Friday's Mid-Day Session
October 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021
October 08, 2021
From Benzinga
Mid-Morning Market Update: Markets Edge Higher; US Economy Adds 194,000 Jobs In September
October 08, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
October 08, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 08, 2021
From Benzinga
18 Stocks Moving in Friday's Pre-Market Session
October 08, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well
October 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 20, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.